Ladapo, Florida's surgeon General (Dr. Joe Ladapo) calls for halt on mRNA covid vaccines in humans! Dr. Joseph Ladapo called for at least a temporary end to the use of the most common type of COVID-19

vaccines; Surgeon General outlined concerns regarding nucleic acid contaminants in the approved Pfizer and Moderna COVID-19 mRNA vaccines, particularly in the presence of lipid nanoparticle complexes

https://www.floridahealth.gov/about/_documents/12-06-2023-DOH-Letter-to-FDA-RFI-on-COVID-19-Vaccines.pdf?utm_source=floridahealth.gov&utm_medium=referral&utm_campaign=PressRelease&utm_content=Florida%27s_Future_Budget&url_trace_7f2r5y6=Press_Release_Template_fry_2023_alt.docx

‘The Surgeon General outlined concerns regarding nucleic acid contaminants in the approved Pfizer and Moderna COVID-19 mRNA vaccines, particularly in the presence of lipid nanoparticle complexes, and Simian Virus 40 (SV40) promoter/enhancer DNA. Lipid nanoparticles are an efficient vehicle for delivery of the mRNA in the COVID-19 vaccines into human cells and may therefore be an equally efficient vehicle for delivering contaminant DNA into human cells. The presence of SV40 promoter/enhancer DNA may also pose a unique and heightened risk of DNA integration into human cells.’

BREAKING--Florida Surgeon General Calls for a Complete Halt on Pfizer and Moderna mRNA Vaccines

'By Peter A. McCullough, MD, MPH

Dr. Joseph A. Ladapo is a Harvard-trained MD, PhD, and arguably one of the top experts on COVID-19 in the world. Prior to the Florida Surgeon General appointment, Dr. Ladapo was in academic practice at UCLA and published with myself, Dr. John McKinnon, and Dr. Harvey Risch on the efficacy of early hydroxychloroquine in acute COVID-19.

On December 6th 2023, State Surgeon General Dr. Joseph A. Ladapo sent a letter to the US Food and Drug Administration (FDA) Commissioner Dr. Robert M. Califf and Centre for Disease Control and Prevention (CDC) Director Dr. Mandy Cohen regarding questions pertaining to the discovery of DNA process-related impurities found in the the Pfizer and Moderna COVID-19 mRNA vaccines.

Ladapo’s concerns center around lipid nanoparticles laced with Simian Virus 40 (SV40) promoter/enhancer/origin of insertion DNA sequences widely distributed through the body. SV40 is a known promoter of proto-oncogenes.

The 2007, the FDA ‘Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications (Guidance for Industry) outlines important considerations for vaccines that use novel methods of delivery regarding DNA integration, specifically:

• DNA integration could theoretically impact a human’s oncogenes – the genes which can transform a healthy cell into a cancerous cell.

• DNA integration may result in chromosomal instability.

• The Guidance for Industry discusses biodistribution of DNA vaccines and how such integration could affect unintended parts of the body including blood, heart, brain, liver, kidney, bone marrow, ovaries/testes, lung, draining lymph nodes, spleen, the site of administration and subcutis at injection site.

The FDA provided a written response on December 14, 2023, indicating the sponsors have NOT addressed risks outlined by the FDA itself in 2007. Because the FDA failed to handle these concerns, Dr. Ladapo has released the following statement:

The FDA’s response does not provide data or evidence that the DNA integration assessments it recommended itself have been performed. Instead, it pointed to genotoxicity studies – which are inadequate assessments for DNA integration risk. In addition, it obfuscated the difference between the SV40 promoter/enhancer and SV40 proteins, two elements that are distinct.

DNA integration poses a unique and elevated risk to human health and to the integrity of the human genome, including the risk that DNA integrated into sperm or egg gametes could be passed onto offspring of mRNA COVID-19 vaccine recipients. If the risks of DNA integration have not been assessed for mRNA COVID-19 vaccines, these vaccines are not appropriate for use in human beings.

Providers concerned about patient health risks associated with COVID-19 should prioritize patient access to non-mRNA COVID-19 vaccines and treatment. It is my hope that, in regard to COVID-19, the FDA will one day seriously consider its regulatory responsibility to protect human health, including the integrity of the human genome.